David Mou

David Mou was named CEO in May 2022, adding to his previous responsibilities as Chief Medical Officer. Mou is also currently the Director of Innovations Council at MGH Psychiatry. Additionally, Mou is a Member of Janssen's Neuroscience Strategy Executive Council.